Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Published Online
on August 28, 2008

Stroke. 2008
Published online before print August 28, 2008, doi: 10.1161/STROKEAHA.108.520304
A more recent version of this article appeared on December 1, 2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
39/12/3405    most recent
STROKEAHA.108.520304v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Henning, E. C.
Right arrow Articles by Warach, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Henning, E. C.
Right arrow Articles by Warach, S.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Related Collections
Right arrow Animal models of human disease
Right arrow CT and MRI
Right arrow Acute Cerebral Infarction
Right arrow Pathology of Stroke

Submitted on March 14, 2008
Accepted on April 22, 2008

Reperfusion-Associated Hemorrhagic Transformation in SHR Rats. Evidence of Symptomatic Parenchymal Hematoma

Erica C. Henning PhD*; Lawrence L. Latour PhD; John M. Hallenbeck MD; and Steven Warach MD, PhD

From the Sections on Stroke Diagnostics and Therapeutics (E.C.H., L.L.L., S.W.), and Clinical Investigations (J.M.H.), and the Stroke Branch (E.C.H., L.L.L., J.M.H., S.W.), National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Md.

* To whom correspondence should be addressed. E-mail: henninge{at}ninds.nih.gov.

Background and Purpose—Symptomatic hemorrhagic transformation (HT) is the most important complicating factor after treatment with intravenous tissue plasminogen activator. In this study, we used multimodal magnetic resonance imaging to investigate the incidence and severity of reperfusion-based HT in spontaneously hypertensive rats after ischemia/reperfusion.

Methods—Twenty male spontaneously hypertensive rats were subjected to 30 minutes of middle cerebral artery occlusion via the suture model. Diffusion-weighted, T2-weighted, and gradient-echo imaging were performed on days 1, 2, 3, 4, and 7 for longitudinal evaluation of lesion evolution, vasogenic edema, and HT, respectively. Findings on gradient-echo images were classified according to the severity of hemorrhage: no HT; punctate or small petechial hemorrhage (HI-1); confluent petechial hemorrhage (HI-2); hematoma with absent/mild space-occupying effect (PH-1, ≤30% lesion volume); and hematoma with significant space-occupying effect and potential perihematomal edema (PH-2, >30% lesion volume). Histopathologic evaluation of HT was performed after final imaging for comparison with magnetic resonance imaging results.

Results—Final hemorrhage scores based on severity were as follows: HI-1 23.1%, HI-2 30.8%, PH-1 30.8%, and PH-2 15.4%. Similar to clinical observations, only PH-2 was associated with neurologic deterioration and associated weight loss.

Conclusions—This model has a high incidence of parenchymal hematomas (46.2%) and therefore is appropriate for the evaluation of novel therapeutics targeting blood-brain barrier integrity and the reduction of symptomatic HT events (PH-2), as well as those potentially "at risk" for neurologic deterioration (PH-1).


Key words: stroke • reperfusion • hemorrhagic transformation • parenchymal hematoma • spontaneously hypertensive rats • middle cerebral artery occlusion